CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 81 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,140,000 | +1400.0% | 88,892 | +568.6% | 0.10% | +1385.7% |
| Q2 2021 | $76,000 | -58.7% | 13,295 | -78.6% | 0.01% | -78.1% |
| Q3 2020 | $184,000 | +360.0% | 62,022 | +478.3% | 0.03% | +700.0% |
| Q4 2019 | $40,000 | -93.0% | 10,725 | -90.5% | 0.00% | -87.9% |
| Q1 2019 | $574,000 | +185.6% | 112,568 | +7.7% | 0.03% | +200.0% |
| Q4 2018 | $201,000 | +204.5% | 104,506 | +523.4% | 0.01% | +266.7% |
| Q4 2017 | $66,000 | -14.3% | 16,764 | -44.8% | 0.00% | -25.0% |
| Q3 2017 | $77,000 | – | 30,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |